Nordic Bioproducts Group (NBG), a Finnish biomaterials company originating from research at Aalto University, has secured a strategic minority investment from Japan-based Oji Holdings Corporation, one of the world’s leading forest-based materials groups. The transaction provides Oji with a 20% ownership stake in NBG and establishes a long-term partnership focused on industrial collaboration, technology deployment, and global market development.

NBG develops next-generation cellulose technologies through its patented AaltoCell® platform, which converts forest biomass into high-value, low-impact cellulose materials. The partnership will initially focus on the production of microcrystalline cellulose (MCC), a specialty ingredient widely used in pharmaceuticals, nutraceuticals, food, and personal care products, within a global market valued at approximately USD 1.33 billion and expected to grow significantly in the coming years.

The investment supports the international scale-up of NBG’s technology and the commercialization of sustainable biomaterials produced from renewable forest resources. With a commercial-scale production facility in Lappeenranta, Finland, NBG is positioned to accelerate the industrial development of cellulose-based materials while expanding its presence in global markets.

Carner Corporate Finance (IMAP Finland) acted as exclusive financial advisor to Nordic Bioproducts Group in the transaction, continuing its long-standing collaboration with the company and supporting the strategic partnership with Oji Holdings.